Biogenically synthesized Moringa oleifera leaf extract-derived silver nanoparticles exhibit potent antimicrobial and anticancer effects via oxidative stress and apoptotic pathways in AGS gastric cancer cells
Kaavyaunni , S. Antony , Kanagaraj Muthu-Pandian Chanthini
{"title":"Biogenically synthesized Moringa oleifera leaf extract-derived silver nanoparticles exhibit potent antimicrobial and anticancer effects via oxidative stress and apoptotic pathways in AGS gastric cancer cells","authors":"Kaavyaunni , S. Antony , Kanagaraj Muthu-Pandian Chanthini","doi":"10.1016/j.bcab.2025.103674","DOIUrl":null,"url":null,"abstract":"<div><div>Silver nanoparticles (AgNPs) possess anticancer and targeted drug delivery potential. When synthesized biogenically, their biocompatibility and therapeutic efficacy are improved through capping with bioactive compounds. This study explores the anticancer potential of silver nanoparticles (AgNPs) synthesized using bioactive compounds from <em>Moringa oleifera</em> (MOAgNPs) against AGS gastric cancer cells. UV–Vis spectrometry confirmed MOAgNP synthesis with peaks at 255.72 and 301.04 nm, while FT-IR revealed O-H and carbonyl groups crucial for nanoparticle stability; DLS analysis showed a narrow particle size distribution with an average diameter of 30–35 nm, consistent with TEM observations. Microscopy confirmed spherical nanoparticles with a diameter of 30–35 nm, while a zeta potential of −24.9 mV indicated colloidal stability. MOAgNPs demonstrated cytotoxicity with an IC50 of 55.213 μg/mL, inducing ROS generation, apoptosis, and cellular morphology changes. Downregulation of key proteins involved in energy metabolism and apoptosis highlighted MOAgNPs' ability to impair vital cellular functions and enhance the sensitivity of drug-resistant cancer cells, suggesting their potential as effective anticancer agents for gastric cancer treatment.</div></div>","PeriodicalId":8774,"journal":{"name":"Biocatalysis and agricultural biotechnology","volume":"67 ","pages":"Article 103674"},"PeriodicalIF":3.4000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biocatalysis and agricultural biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1878818125001872","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Silver nanoparticles (AgNPs) possess anticancer and targeted drug delivery potential. When synthesized biogenically, their biocompatibility and therapeutic efficacy are improved through capping with bioactive compounds. This study explores the anticancer potential of silver nanoparticles (AgNPs) synthesized using bioactive compounds from Moringa oleifera (MOAgNPs) against AGS gastric cancer cells. UV–Vis spectrometry confirmed MOAgNP synthesis with peaks at 255.72 and 301.04 nm, while FT-IR revealed O-H and carbonyl groups crucial for nanoparticle stability; DLS analysis showed a narrow particle size distribution with an average diameter of 30–35 nm, consistent with TEM observations. Microscopy confirmed spherical nanoparticles with a diameter of 30–35 nm, while a zeta potential of −24.9 mV indicated colloidal stability. MOAgNPs demonstrated cytotoxicity with an IC50 of 55.213 μg/mL, inducing ROS generation, apoptosis, and cellular morphology changes. Downregulation of key proteins involved in energy metabolism and apoptosis highlighted MOAgNPs' ability to impair vital cellular functions and enhance the sensitivity of drug-resistant cancer cells, suggesting their potential as effective anticancer agents for gastric cancer treatment.
期刊介绍:
Biocatalysis and Agricultural Biotechnology is the official journal of the International Society of Biocatalysis and Agricultural Biotechnology (ISBAB). The journal publishes high quality articles especially in the science and technology of biocatalysis, bioprocesses, agricultural biotechnology, biomedical biotechnology, and, if appropriate, from other related areas of biotechnology. The journal will publish peer-reviewed basic and applied research papers, authoritative reviews, and feature articles. The scope of the journal encompasses the research, industrial, and commercial aspects of biotechnology, including the areas of: biocatalysis; bioprocesses; food and agriculture; genetic engineering; molecular biology; healthcare and pharmaceuticals; biofuels; genomics; nanotechnology; environment and biodiversity; and bioremediation.